Plenco 574

Product Description

Plenco 574 is a phenolic molding compound manufactured by Plenco (Plastics Engineering Company), a Wisconsin-based specialty plastics manufacturer that has operated since the early twentieth century. Phenolic molding compounds of this type belong to a class of thermosetting resins derived from the condensation of phenol and formaldehyde, a chemistry first commercialized under the trade name Bakelite in the early 1900s. Thermosetting plastics, unlike thermoplastics, cure irreversibly under heat and pressure, producing rigid, dimensionally stable parts capable of withstanding elevated temperatures, electrical stress, and mechanical load.

Plenco 574 and related phenolic compounds were formulated for industrial molding operations, where the material was supplied as a powder or granular resin and then compression-molded or transfer-molded into finished components. End uses for phenolic molding compounds historically spanned a wide range of industrial applications, including electrical housings and insulators, appliance components, automotive parts, chemical-resistant equipment, and industrial machinery components. The durability and heat resistance of phenolic resins made them a preferred material in environments where plastics were subject to sustained thermal or mechanical stress.

Plastics Engineering Company marketed its Plenco product lines to manufacturers, fabricators, and molding shops throughout the mid-twentieth century and beyond, making these compounds a common material in industrial production settings across the United States.

Asbestos Content

Phenolic molding compounds of the mid-twentieth century frequently incorporated asbestos fibers as a functional filler or reinforcing agent. Asbestos served several purposes in thermosetting resin formulations: it improved heat resistance, enhanced dimensional stability during molding, reduced shrinkage in finished parts, and added mechanical strength to the cured material. Chrysotile asbestos was the most commonly used fiber type in plastic compound formulations, though other asbestos varieties also appeared in industrial resin products depending on the performance specifications required.

Litigation records document that Plenco 574 was alleged to have contained asbestos as a component of its formulation. Plaintiffs alleged that the compound incorporated asbestos fibers in amounts sufficient to create hazardous airborne fiber concentrations during ordinary processing and handling operations. The specific fiber type and percentage by weight alleged in litigation have varied across individual cases, consistent with the range of formulations documented in the broader phenolic compound product category.

It is worth noting that regulatory attention to asbestos in plastic compounds intensified significantly following the establishment of OSHA’s asbestos standards in the early 1970s and the subsequent findings of the Environmental Protection Agency and the National Toxicology Program confirming the carcinogenicity of all forms of asbestos fiber. AHERA regulations and subsequent federal guidance reinforced the understanding that no safe level of occupational asbestos exposure has been established.

How Workers Were Exposed

Industrial workers involved in the handling, processing, and molding of Plenco 574 and similar phenolic compounds faced potential asbestos fiber exposure at multiple stages of the production cycle. The nature of exposure was tied directly to the physical state of the material and the conditions under which it was processed.

Receiving and material handling: Workers who unloaded, transferred, and weighed raw phenolic compound powder or granules could be exposed to airborne dust generated during those operations. Phenolic molding compounds in powder form are particularly prone to generating respirable dust during any disturbance of the material, including opening bags, emptying containers, and loading hoppers or feed systems.

Molding and pressing operations: Compression molding and transfer molding of phenolic compounds involves loading measured charges of the resin into heated molds under significant mechanical pressure. Workers operating these presses were positioned in close proximity to the mold tooling during charge loading and part ejection, both of which could release residual compound dust into the breathing zone.

Finishing and secondary operations: Molded phenolic parts frequently required post-mold trimming, deflashing, drilling, grinding, or sanding to achieve final dimensional tolerances and surface quality. Litigation records document that these dry machining operations on cured phenolic parts were associated with generation of fine particulate dust that, where asbestos fibers were present in the original compound, could contain respirable asbestos at hazardous concentrations. Workers performing finishing operations without adequate respiratory protection or engineering controls were among those alleged to have sustained the highest cumulative exposures.

Maintenance and cleaning personnel: Plaintiffs alleged that maintenance workers who serviced molding equipment, cleaned mold surfaces, and cleared production areas contaminated with accumulated compound dust were similarly exposed to airborne asbestos fibers released from settled material during cleaning activities, particularly where compressed air was used to blow down equipment.

Tooling and die maintenance workers: Workers responsible for inspecting, cleaning, and repairing mold tooling used with phenolic compounds encountered residual cured and uncured material on tooling surfaces, and their work activities could disturb settled compound dust in enclosed work areas.

Industrial hygiene controls adequate to limit asbestos fiber concentrations to current permissible exposure limits were not uniformly in place during the decades when asbestos-containing phenolic compounds were most widely used. Plaintiffs alleged that workers in molding production environments were not consistently provided with respiratory protection, local exhaust ventilation, or other engineering controls appropriate to the hazard presented by asbestos-containing molding compound dust.

Plenco 574 falls within Tier 2 of the legal framework applicable to asbestos product claims, meaning that claims involving this product have proceeded through the civil litigation system rather than through an established asbestos bankruptcy trust fund. No Plastics Engineering Company asbestos bankruptcy trust has been identified in public trust fund records.

Civil Litigation

Litigation records document that individuals diagnosed with asbestos-related diseases, including mesothelioma, asbestosis, and lung cancer, have brought civil claims in connection with exposure to Plenco-branded phenolic molding compounds. Plaintiffs alleged that Plastics Engineering Company knew or should have known of the hazards associated with asbestos in its product formulations and failed to adequately warn workers or provide sufficient information to enable safe handling of the material.

Individuals who worked with Plenco 574 or similar phenolic compounds and have received a diagnosis of an asbestos-related disease may have the right to pursue a civil claim against responsible parties. Compensable diagnoses in asbestos litigation typically include:

  • Mesothelioma (pleural, peritoneal, or pericardial)
  • Asbestos-related lung cancer
  • Asbestosis
  • Other asbestos-related pleural diseases

Additional Trust Fund Claims

Workers exposed to Plenco 574 in industrial settings were frequently exposed to asbestos from multiple sources simultaneously, including insulation materials, gaskets, packing, and other asbestos-containing products manufactured by companies that have subsequently established bankruptcy trusts. Individuals with qualifying diagnoses may be eligible to file claims with one or more of the more than sixty active asbestos bankruptcy trusts, independent of any litigation involving Plenco specifically.

Recommended Next Steps

Anyone with a history of occupational exposure to Plenco 574 or related phenolic molding compounds who has been diagnosed with mesothelioma, lung cancer, asbestosis, or a related condition should consult with an attorney experienced in asbestos litigation. Statutes of limitations apply to asbestos claims and vary by state, making timely legal consultation essential. Employment records, co-worker testimony, product identification records, and industrial hygiene documentation can all support the development of a claim involving phenolic compound exposure.